ArticleFrontiers in cell and developmental biology2022

METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma.

Liting Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.